Journal of the European Academy of Dermatology and Venereology : JEADV · 2014
2013 European guideline on the management of lymphogranuloma venereum.
СтатьяКлинические рекомендацииНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
de Vries H J C, Zingoni A, Kreuter A, Moi H, White J A, European Branch of the International Union against Sexually Transmitted Infections, European Academy of Dermatology and Venereology, European Dermatology Forum, European Society of Clinical Microbiology and Infectious Diseases, Union of European Medical Specialists, European Centre for Disease Prevention and Control, European Office of the World Health Organisation
Аннотация
UNLABELLED: WHAT IS NEW IN THIS UPDATED GUIDELINE?: This is the update version of the 2010 European guideline on the management of lymphogranuloma venereum (LGV). New issues are:
EPIDEMIOLOGY: Based on clonal relatedness of prevalent LGV strains there is evidence that the LGV epidemic among men who have sex with men (MSM) in the Western world prevailed already in the United States in the 1980s and was introduced into Europe by the end of the last century.
AETIOLOGY AND TRANSMISSION: A new LGV variant causing severe proctitis was unveiled and designated L2c. The L2b LGV variant causing the vast majority of infections among MSM is now also found among a few heterosexual women.
MANAGEMENT: Apart from HIV and STI screening, Hepatitis C Virus (HCV) testing should be offered to all LGV patients. To exclude reinfections, STI screening during a follow-up visit 3 months after an LGV diagnosis should be offered.
EPIDEMIOLOGY: Based on clonal relatedness of prevalent LGV strains there is evidence that the LGV epidemic among men who have sex with men (MSM) in the Western world prevailed already in the United States in the 1980s and was introduced into Europe by the end of the last century.
AETIOLOGY AND TRANSMISSION: A new LGV variant causing severe proctitis was unveiled and designated L2c. The L2b LGV variant causing the vast majority of infections among MSM is now also found among a few heterosexual women.
MANAGEMENT: Apart from HIV and STI screening, Hepatitis C Virus (HCV) testing should be offered to all LGV patients. To exclude reinfections, STI screening during a follow-up visit 3 months after an LGV diagnosis should be offered.